RADNOR, Pa., Dec. 14, 2020 /PRNewsCentre/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the 39th Annual J.P. Morgan Healthcare Conference being held virtually on Monday, January 11, 2021. Michael Stubblefield, President and CEO at Avantor, will represent Avantor in the segment beginning at approximately 9:10 a.m. Eastern Time.
A live webcast may be accessed through the investor relations section of Avantor’s website at https://ir.avantorsciences.com/investors/events-and-presentations/ and will be available for replay through January 31, 2021.
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit www.avantorsciences.com.
Senior Vice President, Global Communications
Investor Relations Contact
Tommy J. Thomas, CPA
Vice President, Investor Relations
SOURCE: Avantor and Financial News